4 Reasons Why You Should Put Surface Oncology on your Watchlist!
A clinical stage Immuno-oncology company, Surface Oncology, Inc. (NASDAQ: SURF) is developing a diverse pipeline of candidates that target the immune system to combat various forms of cancer. The Company’s pipeline consists of candidates in four key areas namely macrophages and natural killer cells,...
